Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | ($47.6) | ($71.0) | ($99.1) | ($3.2) | ($3.4) | ($2.7) | ($1.5) | ($1.2) | ($1.1) | ($0.8) | ($0.9) | ($1.3) | ($0.5) | ($0.5) | $0.1 | $0.2 | $0.1 | $0.3 | $0.1 | $3.0 |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Insulet Corporation's last 12-month EPS is $6.1, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Insulet Corporation's EPS growth was 256.1%. The average annual EPS growth rates for Insulet Corporation have been 244.4% over the past three years, 86.5% over the past five years.
Over the last year, Insulet Corporation's EPS growth was 256.1%, which is higher than industry growth of (0.2%). It indicates that Insulet Corporation's EPS growth is Good.